RESUMO
A 77-year-old man with a history of lung cancer at the age of 71 developed involuntary right leg movement for a month. Neurological examination revealed a right-sided hemi-chorea. Autoimmune disease was suspected owing to the presence of oligoclonal bands and the elevated IgG-index in the cerebrospinal fluid. We detected anti-SRY-Related HMG-Box Gene 1 (SOX1) antibodies, known to be serological markers of Lambert-Eaton syndrome with small cell lung cancer, but not tumors. The results of tests for antiphospholipid, anti-LGI1, and anti-CASPR2 antibodies associated with non-paraneoplastic autoimmune chorea were all negative. This is the first suggestive case of autoimmune chorea in which anti-SOX1 antibodies were detected.
Assuntos
Autoanticorpos/sangue , Autoimunidade , Coreia/etiologia , Coreia/imunologia , Fatores de Transcrição SOXB1/imunologia , Idoso , Biomarcadores/sangue , Encéfalo/diagnóstico por imagem , Coreia/diagnóstico , Imagem de Difusão por Ressonância Magnética , Humanos , Síndrome Miastênica de Lambert-Eaton/complicações , Neoplasias Pulmonares/complicações , Masculino , Carcinoma de Pequenas Células do Pulmão/complicaçõesRESUMO
Background: Pure acute onset chorea without encephalopathy has rarely been reported in anti-thyroid peroxidase (anti-TPO)/anti-thyroglobulin (anti-TG) antibody-related neurologic disorders responsive to steroids (ATANDS). Case report: We report a 16-year-old female who presented with acute chorea without encephalopathy. Anti-TPO antibodies were found to be strongly positive (>1200 IU/ml) along with anti-thyroglobulin and anti-thyroid stimulating hormone receptor antibodies. After pulse intravenous methylprednisolone therapy (1 g/day for five consecutive days), all the movements seized, and she was discharged with oral prednisolone 30 mg/day with gradual tapering over next three months. After one year of follow-up, she is stable, drug-free, and never had any other problems. Discussion: Anti-thyroid antibodies testing should be included in routine/conventional panel that is done for elucidating causes of chorea as ATANDS can be easily missed and is treatable with widely available, relatively low-cost drugs like steroids with a promising outcome.
Assuntos
Autoantígenos/imunologia , Doenças Autoimunes do Sistema Nervoso/imunologia , Coreia/imunologia , Iodeto Peroxidase/imunologia , Proteínas de Ligação ao Ferro/imunologia , Esteroides/farmacologia , Tireoglobulina/imunologia , Adolescente , Doenças Autoimunes do Sistema Nervoso/complicações , Doenças Autoimunes do Sistema Nervoso/diagnóstico , Doenças Autoimunes do Sistema Nervoso/tratamento farmacológico , Coreia/diagnóstico , Coreia/tratamento farmacológico , Coreia/etiologia , Feminino , Humanos , Metilprednisolona/farmacologia , Esteroides/administração & dosagemAssuntos
Coreia/imunologia , Hidrolases/imunologia , Linfoma Difuso de Grandes Células B/complicações , Proteínas Associadas aos Microtúbulos/imunologia , Síndromes Paraneoplásicas do Sistema Nervoso/imunologia , Idoso , Autoanticorpos/sangue , Autoanticorpos/imunologia , Autoantígenos/imunologia , Humanos , MasculinoAssuntos
Encefalopatias/genética , Encefalopatias/terapia , Moléculas de Adesão Celular Neuronais/genética , Imunoglobulinas Intravenosas/uso terapêutico , Fatores Imunológicos/uso terapêutico , Encefalopatias/imunologia , Coreia/genética , Coreia/imunologia , Coreia/terapia , Disfunção Cognitiva/genética , Disfunção Cognitiva/imunologia , Disfunção Cognitiva/terapia , Humanos , Masculino , Pessoa de Meia-Idade , FenótipoRESUMO
Among the neurological manifestations of systemic lupus erythematosus (SLE), chorea is rare, presenting in less than 7% of the pediatric SLE patients. It can appear early in the onset of SLE, be the first or even the sole clinical feature of the illness and has strongly been associated with the presence of antiphospholipid antibodies. We report on the case of a 13-year old boy, admitted with acute onset chorea and finally diagnosed with SLE. Subsequently, we present a short review of the literature on the epidemiology, suggested pathogenesis, clinical presentation and treatment of this rare presentation of SLE.
Assuntos
Coreia/imunologia , Glucocorticoides/uso terapêutico , Lúpus Eritematoso Sistêmico/diagnóstico , Síndrome de Sweet/diagnóstico , Adolescente , Antidiscinéticos/uso terapêutico , Anticonvulsivantes/uso terapêutico , Biópsia/efeitos adversos , Encéfalo/diagnóstico por imagem , Encéfalo/imunologia , Coreia/diagnóstico por imagem , Coreia/tratamento farmacológico , Complemento C3/análise , Diagnóstico Diferencial , Erros de Diagnóstico , Humanos , Inibidor de Coagulação do Lúpus/sangue , Lúpus Eritematoso Sistêmico/sangue , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Lúpus Eritematoso Sistêmico/imunologia , Imageamento por Ressonância Magnética , Masculino , Pele/imunologia , Pele/patologia , Síndrome de Sweet/patologiaRESUMO
Chorea is associated with involuntary movement and may occur via an autoimmune mechanism. Until now, we treated immune-mediated chorea with glucocorticoids and cyclophosphamide as the efficacy of mycophenolate mofetil (MMF) therapy for this condition was unknown. Here, we report two cases of antiphospholipid antibody (aPL)-associated chorea that were cured by MMF. Measurement of aPL could help for future management of chorea patients. This report provides new insight into the beneficial effects of MMF on aPL-associated chorea.
Assuntos
Coreia/tratamento farmacológico , Imunossupressores/uso terapêutico , Ácido Micofenólico/uso terapêutico , Adolescente , Anticorpos Antifosfolipídeos/sangue , Criança , Coreia/sangue , Coreia/imunologia , Feminino , Humanos , Imunossupressores/administração & dosagem , Ácido Micofenólico/administração & dosagemRESUMO
Rheumatic fever (RF) and rheumatic heart disease (RHD) follow untreated S. pyogenes throat infections in children who present susceptible genes that favor the development of autoimmune reactions. In this review, we focus on the genes that confer susceptibility and on the autoimmune reactions that occur due to molecular mimicry between human-tissue proteins and streptococcal M protein. Polyarthritis is the initial manifestation, which can evolve to carditis and severe valve damage; these culminate in rheumatic heart disease (RHD) or Sydenham's chorea, which affects the central nervous system. A perspective on vaccine development to prevent the disease is also discussed.
Assuntos
Cardiopatia Reumática/metabolismo , Cardiopatia Reumática/prevenção & controle , Vacinas/uso terapêutico , Autoimunidade , Coreia/etiologia , Coreia/imunologia , Coreia/metabolismo , Coreia/prevenção & controle , Citocinas/metabolismo , Antígenos de Histocompatibilidade Classe II/genética , Humanos , Mimetismo Molecular , Febre Reumática/etiologia , Febre Reumática/imunologia , Febre Reumática/metabolismo , Febre Reumática/prevenção & controle , Cardiopatia Reumática/etiologia , Cardiopatia Reumática/imunologia , Streptococcus pyogenesRESUMO
68-year-old female presented with involuntary movements. MRI was normal. Cerebrospinal fluid analysis was normal. whole body CT and biopsy confirmed diagnosis of metastatic adenocarnimoa. The autoimmune panel was positive for anti-Yo antibodies.
Assuntos
Anticorpos/sangue , Coreia/imunologia , Discinesias/imunologia , Proteínas do Tecido Nervoso/imunologia , Síndromes Paraneoplásicas do Sistema Nervoso/imunologia , Células de Purkinje/imunologia , Idoso , Coreia/sangue , Discinesias/sangue , Feminino , Humanos , Imageamento por Ressonância Magnética , Síndromes Paraneoplásicas do Sistema Nervoso/sangueRESUMO
Chorea, a movement disorder characterised by a continuous flow of unpredictable muscle contractions, has a myriad of genetic and non-genetic causes. Although autoimmune processes are rare aetiology of chorea, they are relevant both for researchers and clinicians. The aim of this article is to provide a review of the epidemiology, clinical and laboratory features, pathogenesis and management of the most common autoimmune causes of chorea. Emphasis is given particularly to Sydenham's chorea, systemic lupus erythematosus, primary antiphospolipid antibody syndrome, paraneoplastic chorea and anti-N-methyl-d-aspartate receptor encephalitis.
Assuntos
Doenças Autoimunes do Sistema Nervoso/diagnóstico , Coreia/epidemiologia , Coreia/imunologia , Encefalite Antirreceptor de N-Metil-D-Aspartato/diagnóstico , Doenças Autoimunes do Sistema Nervoso/etiologia , Humanos , Lúpus Eritematoso Sistêmico/diagnósticoRESUMO
The mechanisms involved in the symptoms of Sydenham’s chorea (SC) remain obscure. Taking into account the autoreactive antibody-mediated hypothesis of SC pathogenesis, the persistence of chorea may be associated with increased levels of B1 lymphocytes and other lymphocyte subsets. We evaluated lymphocyte subsets, including B1 and T cells, in patients with remitted (RSC) and persistent (PSC) SC by flow cytometry. Our results showed neither difference in the frequency of T and B lymphocytes subpopulations nor in their activation and functional states. These findings undermine the view of PSC as a sustained cytotoxic cellular-mediated condition. Alternative mechanisms may explain the pathogenesis of PSC.
Os mecanismos subjacentes aos sintomas da coreia de Sydenham (CS) permanecem desconhecidos. Considerando-se a hipótese de que a patogênese da CS é mediada por anticorpos autorreativos, a persistência da coreia está provavelmente associada a níveis aumentados de linfócitos B1 e outros subtipos de linfócitos. No presente trabalho, foram avaliados subtipos de linfócitos B e T em pacientes com CS em remissão (CSR) e persistente (CSP), por citometria de fluxo. Nossos resultados demonstraram que não há diferença na frequência das subpopulações de linfócitos T e B circulantes e no perfil de ativação e estado funcional dessas células. Esses resultados enfraquecem a hipótese de que a CSP seja uma condição imune sustentada mediada por células citotóxicas. São necessários estudos que investiguem mecanismos alternativos que expliquem a patogênese da CSP.
Assuntos
Adolescente , Adulto , Feminino , Humanos , Masculino , Adulto Jovem , Autoimunidade/fisiologia , Subpopulações de Linfócitos B/patologia , Coreia/imunologia , Subpopulações de Linfócitos T/patologia , Subpopulações de Linfócitos B/imunologia , Citometria de Fluxo , Contagem de Linfócitos , Subpopulações de Linfócitos T/imunologiaRESUMO
The mechanisms involved in the symptoms of Sydenham's chorea (SC) remain obscure. Taking into account the autoreactive antibody-mediated hypothesis of SC pathogenesis, the persistence of chorea may be associated with increased levels of B1 lymphocytes and other lymphocyte subsets. We evaluated lymphocyte subsets, including B1 and T cells, in patients with remitted (RSC) and persistent (PSC) SC by flow cytometry. Our results showed neither difference in the frequency of T and B lymphocytes subpopulations nor in their activation and functional states. These findings undermine the view of PSC as a sustained cytotoxic cellular-mediated condition. Alternative mechanisms may explain the pathogenesis of PSC.
Assuntos
Autoimunidade/fisiologia , Subpopulações de Linfócitos B/patologia , Coreia/imunologia , Subpopulações de Linfócitos T/patologia , Adolescente , Adulto , Subpopulações de Linfócitos B/imunologia , Feminino , Citometria de Fluxo , Humanos , Contagem de Linfócitos , Masculino , Subpopulações de Linfócitos T/imunologia , Adulto JovemRESUMO
Antineuronal autoantibodies are associated with the involuntary movement disorder Sydenham chorea (SC) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) which are characterized by the acute onset of tics and/or obsessive compulsive disorder (OCD). In SC and PANDAS, autoantibodies signal human neuronal cells and activate calcium calmodulin-dependent protein kinase II (CaMKII). Animal models immunized with group A streptococcal antigens demonstrate autoantibodies against dopamine receptors and concomitantly altered behaviours. Human monoclonal antibodies (mAbs) derived from SC target and signal the dopamine D2L (long) receptor (D2R). Antibodies against D2R were elevated over normal levels in SC and acute-onset PANDAS with small choreiform movements, but were not elevated over normal levels in PANDAS-like chronic tics and OCD. The expression of human SC-derived anti-D2R autoantibody V gene in B cells and serum of transgenic mice demonstrated that the human autoantibody targets dopaminergic neurones in the basal ganglia and other types of neurones in the cortex. Here, we review current evidence supporting the hypothesis that antineuronal antibodies, specifically against dopamine receptors, follow streptococcal exposures and may target dopamine receptors and alter central dopamine pathways leading to movement and neuropsychiatric disorders.
Assuntos
Autoimunidade/imunologia , Coreia/imunologia , Transtornos dos Movimentos/imunologia , Transtornos dos Movimentos/psicologia , Receptores Dopaminérgicos/metabolismo , Animais , Autoanticorpos/imunologia , Autoimunidade/fisiologia , Coreia/psicologia , Humanos , Receptores Dopaminérgicos/imunologia , Infecções Estreptocócicas/imunologiaRESUMO
INTRODUCTION: Herpes simplex encephalitis is a severe neurological condition, whose outcome is improved if treated early with acyclovir. Post-herpes simplex encephalitis with acute chorea has rarely been reported. CASE REPORT: We report on two observations of children presenting with post-herpes simplex encephalitis with acute chorea, related to two different pathophysiological mechanisms. The first one is an 11-month-old girl developing relapsing herpes simplex encephalitis with chorea due to resumption of viral replication. The second one is a 2-year-old boy with relapsing post-herpes simplex encephalitis acute chorea caused by an immunoinflammatory mechanism. We discuss the different neurological presentations of herpetic relapses, notably those presenting with movement disorders, as well as their clinical, paraclinical, physiopathological, and therapeutic aspects. CONCLUSION: Post-herpes simplex encephalitis with acute chorea may involve two mechanisms: resumption of viral replication or an immunoinflammatory mechanism. Treatment of post-herpes simplex encephalitis with acute chorea depends on the underlying mechanism, while prevention is based on antiviral treatment of herpes simplex encephalitis with acyclovir at the dose of 20mg/kg/8h for 21 days.
Assuntos
Aciclovir/uso terapêutico , Antivirais/uso terapêutico , Coreia/tratamento farmacológico , Coreia/virologia , Encefalite por Herpes Simples/complicações , Encefalite por Herpes Simples/tratamento farmacológico , Criança , Pré-Escolar , Coreia/diagnóstico , Coreia/imunologia , Consanguinidade , Encefalite por Herpes Simples/diagnóstico , Encefalite por Herpes Simples/imunologia , Feminino , Humanos , Masculino , Recidiva , Fatores de Risco , Resultado do TratamentoRESUMO
In recent years, autoantibodies to proteins or receptors expressed on the surface of neurons have been detected in movement and psychiatric disorders. These autoantibodies can assist in better recognition of clinical syndromes and offer novel treatment opportunities via immunotherapies, potentially leading to improved patient outcome. In this review, we describe several autoimmune syndromes associated with movement and psychiatric disorders, including anti-N-methyl-d-aspartate receptor encephalitis, basal ganglia encephalitis, Sydenham chorea, and autoantibody-associated psychosis and schizophrenia. However, rather than focusing on clinical aspects of these diseases, as they have been reviewed in detail elsewhere, we mainly focus on the scientific aspects of the different methodologies for detecting antibodies, with an emphasis on the current gold standard in the field, the cell-based assay, and on issues related to the use of live versus permeabilized cells. We also reflect on the implications associated with the choice of patient serum and cerebrospinal fluid for antibody testing, on the mechanism of antibody entry into the central nervous system through the blood-brain barrier, and the essential issue of antibody pathogenicity.
Assuntos
Autoanticorpos/sangue , Doenças Autoimunes/patologia , Imunoterapia/métodos , Encefalite Antirreceptor de N-Metil-D-Aspartato/patologia , Doenças Autoimunes/psicologia , Doenças Autoimunes/terapia , Doenças dos Gânglios da Base/patologia , Coreia/diagnóstico , Coreia/imunologia , Coreia/terapia , Humanos , Transtornos Psicóticos/diagnóstico , Transtornos Psicóticos/imunologia , Transtornos Psicóticos/terapia , Esquizofrenia/diagnóstico , Esquizofrenia/imunologia , Esquizofrenia/terapiaRESUMO
Several autoantibodies (anti-dopamine 1 (D1R) and 2 (D2R) receptors, anti-tubulin, anti-lysoganglioside-GM1) and antibody-mediated activation of calcium calmodulin dependent protein kinase II (CaMKII) signaling activity are elevated in children with Sydenham's chorea (SC). Recognizing proposed clinical and autoimmune similarities between SC and PANDAS (pediatric autoimmune neuropsychiatric disorder associated with a streptococcal infection), we sought to identify serial biomarker changes in a slightly different population. Antineuronal antibodies were measured in eight children (mean 11.3 years) with chronic, dramatic, recurrent tics and obsessive-compulsive disorder (OCD) associated with a group A ß-hemolytic streptococcal (GABHS) respiratory tract infection, but differing because they lacked choreiform movements. Longitudinal serum samples in most subjects included two pre-exacerbation samples, Exac), one midst Exac (abrupt recurrence of tic/OCD; temporally association with a GABHS infection in six of eight subjects), and two post-Exac. Controls included four groups of unaffected children (n = 70; mean 10.8 years) obtained at four different institutions and published controls. Clinical exacerbations were not associated with a significant rise in antineuronal antibody titers. CaMKII activation was increased at the GABHS exacerbation point in 5/6 subjects, exceeded combined and published control's 95th percentile at least once in 7/8 subjects, and median values were elevated at each time point. Anti-tubulin and anti-D2R titers did not differ from published or combined control group's 95th percentile or median values. Differences in anti-lysoganglioside-GM1 and anti-D1R titers were dependent on the selected control. Variances in antibody titers and CaMKII activation were identified among the institutional control groups. Based on comparisons to published studies, results identify two groups of PANDAS: 1) a cohort, represented by this study, which lacks choreiform movements and elevated antibodies against D2R; 2) the originally reported group with choreiform movements and elevated anti-D2R antibodies, similar to SC. Increased antibody mediated CaMKII activation was found in both groups and requires further study as a potential biomarker.
Assuntos
Anticorpos/metabolismo , Coreia/diagnóstico , Progressão da Doença , Neurônios/metabolismo , Transtorno Obsessivo-Compulsivo/etiologia , Infecções Estreptocócicas/complicações , Tiques/etiologia , Adolescente , Antiestreptolisina/metabolismo , Autoanticorpos/metabolismo , Biomarcadores/sangue , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina/metabolismo , Estudos de Casos e Controles , Criança , Coreia/sangue , Coreia/imunologia , Doença Crônica , Desoxirribonucleases/metabolismo , Feminino , Humanos , Imunoglobulina G/metabolismo , Estudos Longitudinais , Masculino , RecidivaRESUMO
The purpose of this task force was to critically analyze nine non-criteria manifestations of APS to support their inclusion as APS classification criteria. The Task Force Members selected the non-criteria clinical manifestations according to their clinical relevance, that is, the patient-important outcome from clinician perspective. They included superficial vein thrombosis, thrombocytopenia, renal microangiopathy, heart valve disease, livedo reticularis, migraine, chorea, seizures and myelitis, which were reviewed by this International Task Force collaboration, in addition to the seronegative APS (SN-APS). GRADE system was used to evaluate the quality of evidence of medical literature of each selected item. This critical appraisal exercise aimed to support the debate regarding the clinical picture of APS. We found that the overall GRADE analysis was very low for migraine and seizures, low for superficial venous thrombosis, thrombocytopenia, chorea, longitudinal myelitis and the so-called seronegative APS and moderate for APS nephropathy, heart valve lesions and livedo reticularis. The next step can be a critical redefinition of an APS gold standard, for instance derived from the APS ACTION registry that will include not only current APS patients but also those with antiphospholipid antibodies not meeting current classification criteria.
Assuntos
Anticorpos Antifosfolipídeos/imunologia , Síndrome Antifosfolipídica/imunologia , Animais , Síndrome Antifosfolipídica/terapia , Coreia/imunologia , Humanos , Mielite/imunologia , Trombocitopenia/imunologia , Resultado do TratamentoRESUMO
The group A streptococcus, Streptococcus pyogenes, and its link to autoimmune sequelae, has acquired a new level of understanding. Studies support the hypothesis that molecular mimicry between the group A streptococcus and heart or brain are important in directing immune responses in rheumatic fever. Rheumatic carditis, Sydenham chorea and a new group of behavioral disorders called pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections are reviewed with consideration of autoantibody and T cell responses and the role of molecular mimicry between the heart, brain and group A streptococcus as well as how immune responses contribute to pathogenic mechanisms in disease. In rheumatic carditis, studies have investigated human monoclonal autoantibodies and T cell clones for their crossreactivity and their mechanisms leading to valve damage in rheumatic heart disease. Although studies of human and animal sera from group A streptococcal diseases or immunization models have been crucial in providing clues to molecular mimicry and its role in the pathogenesis of rheumatic fever, study of human monoclonal autoantibodies have provided important insights into how antibodies against the valve may activate the valve endothelium and lead to T cell infiltration. Passive transfer of anti-streptococcal T cell lines in a rat model of rheumatic carditis illustrates effects of CD4+ T cells on the valve. Although Sydenham chorea has been known as the neurological manifestation of rheumatic fever for decades, the combination of autoimmunity and behavior is a relatively new concept linking brain, behavior and neuropsychiatric disorders with streptococcal infections. In Sydenham chorea, human mAbs and their expression in transgenic mice have linked autoimmunity to central dopamine pathways as well as dopamine receptors and dopaminergic neurons in basal ganglia. Taken together, the studies reviewed provide a basis for understanding streptococcal sequelae and how immune responses against group A streptococci influence autoimmunity and inflammatory responses in the heart and brain.
Assuntos
Linfócitos T CD4-Positivos/imunologia , Coreia/imunologia , Febre Reumática/imunologia , Infecções Estreptocócicas/imunologia , Streptococcus pyogenes/imunologia , Animais , Autoanticorpos/imunologia , Autoimunidade , Gânglios da Base/imunologia , Comportamento/fisiologia , Coreia/etiologia , Reações Cruzadas , Modelos Animais de Doenças , Humanos , Neuroimunomodulação , Receptores Dopaminérgicos/imunologia , Febre Reumática/etiologia , Infecções Estreptocócicas/complicaçõesRESUMO
We reported a 72-year-old man with thymoma who presented with hemichorea. Although his brain CT and MRI revealed no abnormality, regional cerebral blood flow changes, identified by single photon emission computed tomography, suggested that the mechanism underlying the chorea seemed to be a dysfunction of the subthalamic nucleus and pallidum. His hemichorea was completely resolved after thymectomy. Absence of serum anti-neural autoantibodies, including small-cell lung carcinoma-related chorea anti-CRMP-5 antibody, suggests that mechanisms different from cross-talk neural-targeted tumor immune response can be responsible for the thymoma-associated paraneoplastic chorea.